VANCOUVER, BC / ACCESSWIRE / December 30, 2019 / NHS Industries Ltd. (CSE:NHS) (the “Company” or “NHS”) is pleased to provide the following update.
NHS owns an agricultural property located in the Agricultural Land Reserve, (“ALR”) in Langley, British Columbia (the “Langley Property”). The site includes greenhouses and a significant quantity of peat moss which may be used for internal soil mixtures.
The Company continues to pursue its application to the ALR board to have the Langley Property approved for non-farm use. This designation will allow NHS to build out a commercial kitchen and add a potential warehouse in order to allow local growers to create value added products in a turnkey facility.
The Company will continue to seek new business opportunities in the food industry, with a particular focus on innovative food technologies and new food business models.
Change in Board of Directors
The Company announces that David A. Johnson has resigned from the Board of Directors, effective immediately. NHS is pleased to announce that Robert Nygren has been appointed as a new independent director of the Company, effective immediately. Mr. Nygren has practised law in Canada and the US, and has over twenty years of experience leading technology companies based in Canada, US, UK and China.
Carman Parente, President & CEO of NHS stated, “I would like to thank David for his service to the Company and wish him well in the future. I would also like to welcome Robert to the Board.”
About NHS Industries Ltd.
NHS owns 5.5 acres of prime agricultural land in Langley, BC that includes over 48,000 square feet of greenhouse capacity. For further information about NHS, please consult the Company’s profile on SEDAR at www.sedar.com.
On Behalf of the Board of Directors
President and Chief Executive Officer
This news release contains forward-looking statements, which relate to future events or future performance and reflect management’s current expectations and assumptions. Such forward-looking statements reflect management’s current beliefs and are based on assumptions made by and information currently available to the Company. Readers are cautioned that these forward looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected including, but not limited to completion of planned improvements on schedule and on budget, the availability of financing needed to complete the Company’s planned improvements on commercially reasonable terms, delays in obtaining statutory and/or regulatory approval for production plans, the ability to mitigate the risk of loss through appropriate insurance policies, among others. These forward-looking statements are made as of the date hereof and the Company does not assume any obligation to update or revise them to reflect new events or circumstances save as required under applicable securities legislation. This news release does not constitute an offer to sell securities and the Company is not soliciting an offer to buy securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.
This news release does not constitute an offer of securities for sale in the United States. These securities have not and will not be registered under United States Securities Act of 1933, as amended, or any state securities laws and may not be offered or sold in the United States or to a U.S. Person unless so registered, or an exemption from registration is relied upon.
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
SOURCE: NHS Industries Ltd.
View source version on accesswire.com: